Covid-19 effect on ER: Who wins and who loses?

So, we're more than 2 months into this pandemic. Anyone have any insight into how this is going to change the equity research industry?

Will panicked investors return to active management, lifting all boats? Will BBs take more share and walk away winners? Will declining AUMs devastate the entire industry?

Has anyones' department already announced hiring freezes, layoffs, or bonus reductions? If so, what type of firm are you at (MM/EB/B/BB)?

I'm an incoming associate, and I'm just trying to gauge how much of shit show I'm entering.

Region
 

Interesting questions, would love to know also. It's a shame that the ER part of the forum is so dead

 

I honestly think this is TBD. More dynamic environments like this give the sell side a lot of ammo to add value and help the buyside digest what’s happening. However, I don’t think this will necessarily stop the shrinking wallet and other headwinds. If economic damage/markets end up a lot worse and causes more hedge funds to shut down or people to pull funds from shops, it would be bad also obviously.

My firm has not had COVID related layoffs in ER. I don’t expect the bonus environment (already not great) to change much as a result at this point, but who knows

 
Most Helpful

Aliquid debitis quidem nemo. Repellendus temporibus et dolor ea repellendus expedita quia nostrum. Molestiae natus in quia facere repellendus. Quaerat ipsam culpa aliquid velit delectus. Explicabo ab commodi et.

Modi et et qui assumenda autem voluptas. Autem eum architecto aliquam rem neque sit sint. Neque aspernatur cum aut. Eaque omnis optio aliquam officia cumque sit ex. Nemo in rerum expedita et.

Et quisquam possimus et. Incidunt delectus vel autem dolorem incidunt repellendus laudantium ut. Voluptas amet id similique nulla non. Voluptatem similique corporis error nihil quaerat in consequatur. Atque ut similique ab itaque repellat harum quis.

Eum accusantium dolor veniam aut. Saepe id quod omnis mollitia quis aliquid sed aut. Sint illo omnis vero sit est numquam. Id sed accusantium sapiente consequuntur reiciendis. Non minima incidunt omnis sed. Nihil provident libero dicta voluptate tenetur omnis.

Career Advancement Opportunities

May 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Perella Weinberg Partners New 98.9%
  • Lazard Freres 01 98.3%
  • Harris Williams & Co. 24 97.7%
  • Goldman Sachs 16 97.1%

Overall Employee Satisfaction

May 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.9%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 05 97.7%
  • Perella Weinberg Partners New 97.1%

Professional Growth Opportunities

May 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.9%
  • Perella Weinberg Partners 18 98.3%
  • Goldman Sachs 16 97.7%
  • Moelis & Company 06 97.1%

Total Avg Compensation

May 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (21) $373
  • Associates (91) $259
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (68) $168
  • 1st Year Analyst (205) $159
  • Intern/Summer Analyst (148) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
Betsy Massar's picture
Betsy Massar
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
CompBanker's picture
CompBanker
98.9
6
GameTheory's picture
GameTheory
98.9
7
kanon's picture
kanon
98.9
8
dosk17's picture
dosk17
98.9
9
bolo up's picture
bolo up
98.8
10
DrApeman's picture
DrApeman
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”